| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2007 | CA2823946A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/08/2007 | CA2659215A1 Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
| 02/08/2007 | CA2617692A1 Combinations containing ikk-.beta. inhibitors |
| 02/08/2007 | CA2617690A1 Treatment of tumours with ikk-.beta. inhibitors |
| 02/08/2007 | CA2617679A1 Inhibitors of serine proteases |
| 02/08/2007 | CA2617654A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| 02/08/2007 | CA2617589A1 Dihydropteridinones in the treatment of respiratory diseases |
| 02/08/2007 | CA2617546A1 Use of flibanserin in the treatment of obesity |
| 02/08/2007 | CA2617413A1 2-aminoaryl pyridines as protein kinases inhibitors |
| 02/08/2007 | CA2617406A1 New salt iii |
| 02/08/2007 | CA2617404A1 New salt ii |
| 02/08/2007 | CA2617403A1 New salt i |
| 02/08/2007 | CA2617310A1 Methods of preparing hetercyclic boronic acids and derivatives thereof |
| 02/08/2007 | CA2617286A1 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 02/08/2007 | CA2617282A1 Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 02/08/2007 | CA2617256A1 Cyclic amine compound |
| 02/08/2007 | CA2617255A1 Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin |
| 02/08/2007 | CA2617213A1 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 02/08/2007 | CA2617211A1 Amorphous aprepitant coprecipitates |
| 02/08/2007 | CA2617170A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |
| 02/08/2007 | CA2617164A1 Alcohol resistant pharmaceutical formulations |
| 02/08/2007 | CA2617150A1 Use of chk2 kinase inhibitors for cancer treatment |
| 02/08/2007 | CA2617147A1 Formulation of radioprotective .alpha.,.beta. unsaturated aryl sulfones |
| 02/08/2007 | CA2617146A1 Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene |
| 02/08/2007 | CA2617127A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
| 02/08/2007 | CA2617104A1 Amyloid beta receptor and uses thereof |
| 02/08/2007 | CA2617103A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2617102A1 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists |
| 02/08/2007 | CA2617099A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2617096A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2617090A1 Hydrochlorides and hydrates of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methy l-7-(2-butyn-1-yl)-8-(3-amino-piperidin-1-yl)xanthine,their preparation and their use as medicaments |
| 02/08/2007 | CA2617055A1 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity |
| 02/08/2007 | CA2617003A1 Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory |
| 02/08/2007 | CA2616954A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2616941A1 Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders |
| 02/08/2007 | CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/08/2007 | CA2616891A1 Hepatitis c antivirals |
| 02/08/2007 | CA2616806A1 Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof |
| 02/08/2007 | CA2616702A1 Methods for preventing and treating metabolic disorders and new pyrazole-o-glycoside derivatives |
| 02/08/2007 | CA2616685A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 02/08/2007 | CA2616677A1 Cathepsin k inhibitors |
| 02/08/2007 | CA2616669A1 Squaric acid derivatives_ii |
| 02/08/2007 | CA2616608A1 Ep4 receptor agonist, compositions and methods thereof |
| 02/08/2007 | CA2616604A1 Ep4 receptor agonist, compositions and methods thereof |
| 02/08/2007 | CA2616510A1 Cycloalkyl amino-hydantoin compounds and use thereof for .beta.-secretase modulation |
| 02/08/2007 | CA2616461A1 Pdt treatment method for cellulites and cosmetic use |
| 02/08/2007 | CA2616453A1 Novel polyquinoline derivatives and the therapeutic use thereof |
| 02/08/2007 | CA2616366A1 Novel pharmaceutical compounds |
| 02/08/2007 | CA2616337A1 Caspase inhibitor prodrugs |
| 02/08/2007 | CA2616294A1 Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors |
| 02/08/2007 | CA2616184A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
| 02/08/2007 | CA2616181A1 Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily |
| 02/08/2007 | CA2616159A1 Benzimidazoles useful as inhibitors of protein kinases |
| 02/08/2007 | CA2615912A1 Lotion preparation containing pyridonecarboxylic acid derivative |
| 02/08/2007 | CA2615903A1 Quinoline derivatives as antibacterial agents |
| 02/08/2007 | CA2615901A1 Quinoline derivatives as antibacterial agents |
| 02/08/2007 | CA2615900A1 Quinoline derivatives as antibacterial agents |
| 02/08/2007 | CA2615890A1 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 02/08/2007 | CA2615886A1 Bicyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic |
| 02/08/2007 | CA2615758A1 Novel substituted azetidinones |
| 02/08/2007 | CA2615669A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/08/2007 | CA2615592A1 Antitumoral compounds |
| 02/08/2007 | CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/08/2007 | CA2615463A1 Heterocyclic benzodiazepine cgrp receptor antagonists |
| 02/08/2007 | CA2615440A1 Potassium channel inhibitors |
| 02/08/2007 | CA2615209A1 Mc4r-ag0nists for the treatment of urinary tract dysfunction |
| 02/08/2007 | CA2614981A1 Antibacterial quinoline derivatives |
| 02/08/2007 | CA2614711A1 Liquid formulation based on a guanidinoacetic acid component |
| 02/08/2007 | CA2614539A1 Compositions for affecting weight loss |
| 02/08/2007 | CA2614334A1 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/08/2007 | CA2614257A1 Inhibitors of checkpoint kinases |
| 02/08/2007 | CA2614157A1 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 02/08/2007 | CA2613518A1 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/08/2007 | CA2613484A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 02/08/2007 | CA2613366A1 Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators |
| 02/08/2007 | CA2612977A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 02/08/2007 | CA2612480A1 Tizanidine compositions and methods of treatment using the compositions |
| 02/08/2007 | CA2609441A1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/08/2007 | CA2606004A1 Dipiperazinyl ketones and related analogues |
| 02/08/2007 | CA2551690A1 Compositions for use with skin |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749832A2 Carbamate and carbazate ketolide antibiotics |
| 02/07/2007 | EP1749831A1 Demethyl-cantharidin platinum complex isomers and their use |
| 02/07/2007 | EP1749830A1 Curcumol derivatives, the compositions comprising the same and the use of the same in the manufacture of medicament |
| 02/07/2007 | EP1749829A1 JNK inhibitors |
| 02/07/2007 | EP1749827A1 Anti-tumor agent |
| 02/07/2007 | EP1749824A1 Benzodiazepine derivatives, their preparation and the therapeutic use thereof |
| 02/07/2007 | EP1749822A1 Novel cysteine protease inhibitors and their therapeutic applications |
| 02/07/2007 | EP1749821A1 Quaternary ammonium salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 02/07/2007 | EP1749820A1 Salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 02/07/2007 | EP1749819A1 (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide hydrates |
| 02/07/2007 | EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2007 | EP1749817A1 Neurogenic pain control agent composition |
| 02/07/2007 | EP1749552A1 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 02/07/2007 | EP1749540A2 Compositions for improving bioavailability of orally administered drugs |
| 02/07/2007 | EP1749539A2 Preventives or remedies for fatty liver |
| 02/07/2007 | EP1749533A1 Metal/thiol biocides |
| 02/07/2007 | EP1749532A1 Drug for remedy or treatment of wound |
| 02/07/2007 | EP1749531A1 Use of megestrol acetate for the treatment of obstructive pulmonary diseases |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |